Literature DB >> 15181091

Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors.

Giovanna Mantovani1, Sara Bondioni, Andrea G Lania, Sabrina Corbetta, Luisa de Sanctis, Marco Cappa, Eliana Di Battista, Philippe Chanson, Paolo Beck-Peccoz, Anna Spada.   

Abstract

Activating mutations of the Gsalpha gene are detected in different endocrine tumors, such as GH-secreting adenomas and toxic thyroid adenomas, and in hyperfunctioning glands from patients with McCune-Albright syndrome (MAS). There is increasing evidence that the Gsalpha gene is subjected to imprinting control and that Gsalpha imprinting plays a key role in the pathogenesis of different human diseases. The aim of this study was to investigate the presence of a parent specificity of Gsalpha mutations in 10 patients affected with MAS and 12 isolated tumors (10 GH-secreting adenomas, one toxic thyroid adenoma, and one hyperfunctioning adrenal adenoma). The parental origin of Gsalpha mutations was assessed by evaluating NESP55 and exon 1A transcripts, which are monoallelically expressed from the maternal and paternal alleles, respectively. By this approach, we demonstrated that in isolated GH-secreting adenomas, as well as in MAS patients with acromegaly, Gsalpha mutations were on the maternal allele. By contrast, the involvement of other endocrine organs in MAS patients was not associated with a particular parent specificity, as precocious puberty and hyperthyroidism were present in patients with mutations on either the maternal or the paternal allele. Moreover, isolated hyperfunctioning thyroid and adrenal adenomas displayed the mutation on the maternal and paternal alleles, respectively. These data confirm the importance of Gsalpha imprinting in the pituitary gland and point out the high degree of tissue specificity of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181091     DOI: 10.1210/jc.2004-0194

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 2.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

3.  Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.

Authors:  Virginie Mariot; Joy Y Wu; Cumhur Aydin; Giovanna Mantovani; Matthew J Mahon; Agnès Linglart; Murat Bastepe
Journal:  Bone       Date:  2010-09-29       Impact factor: 4.398

4.  Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.

Authors:  Serap Turan; Susanne Thiele; Olta Tafaj; Bettina Brix; Zeynep Atay; Saygin Abali; Belma Haliloglu; Abdullah Bereket; Murat Bastepe
Journal:  Bone       Date:  2014-10-18       Impact factor: 4.398

Review 5.  Genomic imprinting of the type 3 thyroid hormone deiodinase gene: regulation and developmental implications.

Authors:  Marika Charalambous; Arturo Hernandez
Journal:  Biochim Biophys Acta       Date:  2012-04-04

6.  Extra-long Gαs variant XLαs protein escapes activation-induced subcellular redistribution and is able to provide sustained signaling.

Authors:  Zun Liu; Serap Turan; Vanessa L Wehbi; Jean-Pierre Vilardaga; Murat Bastepe
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

7.  Extralarge XL(alpha)s (XXL(alpha)s), a variant of stimulatory G protein alpha-subunit (Gs(alpha)), is a distinct, membrane-anchored GNAS product that can mimic Gs(alpha).

Authors:  Cumhur Aydin; Nurgul Aytan; Mathew J Mahon; Hesham A W Tawfeek; Neil W Kowall; Alpaslan Dedeoglu; Murat Bastepe
Journal:  Endocrinology       Date:  2009-05-07       Impact factor: 4.736

8.  Resting Energy Expenditure Is Decreased in Pseudohypoparathyroidism Type 1A.

Authors:  Jeffrey D Roizen; Jennifer Danzig; Veronique Groleau; Shana McCormack; Alex Casella; Jennifer Harrington; Etienne Sochett; Andrew Tershakovec; Babette S Zemel; Virginia A Stallings; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2015-12-28       Impact factor: 5.958

9.  Potential markers of disease behavior in acromegaly and gigantism.

Authors:  Laura C Hernández-Ramírez
Journal:  Expert Rev Endocrinol Metab       Date:  2020-05-06

10.  Preimplantation genetic diagnosis for severe albright hereditary osteodystrophy.

Authors:  Steven A Lietman; James Goldfarb; Nina Desai; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.